Glycyrrhizic acid ameliorates HMGB1-mediated cell death and inflammation after renal ischemia reperfusion injury

American Journal of Nephrology

Volumn 40, Issue 1, 2014, Pages 84-95

  Lau, Arthur ^a,b   Wang, Shuang ^b,c   Liu, Weihua ^a   Haig, Aaron ^b   Zhang, Zhu Xu ^a,b,c   Jevnikar, Anthony M ^a,b,c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Glycyrrhizic acid; HMGB1; Inflammation; Renal ischemia reperfusion injury

Indexed keywords

CXCL1 CHEMOKINE; ETHIDIUM; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; LIPOCORTIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPIDIUM IODIDE; GAMMA INTERFERON; GRANZYME B; MESSENGER RNA; PERFORIN; RANTES; ANTIINFLAMMATORY AGENT; HMGB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; KIDNEY INJURY; KIDNEY TUBULE CELL; KIDNEY TUBULE NECROSIS; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REPERFUSION INJURY; ANTIINFLAMMATORY ACTIVITY; CELL VIABILITY; CYTOKINE RELEASE; DRUG MECHANISM; HISTOLOGY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; NEPHRITIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ACUTE KIDNEY FAILURE; ANIMAL; APOPTOSIS; DRUG EFFECTS; GENETICS; KIDNEY; METABOLISM;

ACUTE KIDNEY INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; KIDNEY; MICE; REPERFUSION INJURY; UP-REGULATION;

EID: 84904520374     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000364908     Document Type: Article

References (49)

1. Shoskes DA, Halloran PF: Delayed graft function in renal transplantation: Etiology, management and long-Term significance. J Urol 1996; 155: 1831-1840
2. Paller MS: Free radical-mediated postischemic injury in renal transplantation. Ren Fail 1992; 14: 257-260
3. Homer-Vanniasinkam S, Crinnion JN, Gough MJ: Post-ischaemic organ dysfunction: A review. Eur J Vasc Endovasc Surg 1997; 14: 195-203
4. Mohib K, Guan Q, Diao H, Du C, Jevnikar AM: Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007; 293:F801-F812
5. Gobe G, Willgoss D, Hogg N, Schoch E, Endre Z: Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 1999; 56: 1299-1304
6. Nogae S, et al: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol 1998; 9: 620-631
7. Du C, et al: Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury. Transplant Proc 2003; 35: 2481-2482
8. Zhang ZX, et al: NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 2008; 181: 7489-7498
9. Rosin DL, Okusa MD: Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 2011; 22: 416-425
10. Pisetsky D: Cell death in the pathogenesis of immune-mediated diseases: The role of HMGB1 and DAMP-PAMP complexes. Swiss Med Wkly 2011; 141:w13256
11. Land WG: Injury to allografts: Innate immune pathways to acute and chronic rejection. Saudi J Kidney Dis Transpl 2005; 16: 520-539
12. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A: HMGB1: Endogenous danger signaling. Mol Med 2008; 14: 476-484
13. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195
14. Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM: HMGB1, TLR and RAGE: A functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets 2011; 15: 1023-1035
15. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165: 2950-2954
16. Andersson U, Tracey KJ: HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011; 29: 139-162
17. Czura CJ, Wang H, Tracey KJ: Dual roles for HMGB1: DNA binding and cytokine. J Endotoxin Res 2001; 7: 315-321
18. Tsung A, et al: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201: 1135-1143
19. Ueno H, et al: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004; 170: 1310-1316
20. Andrassy M, et al: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008; 117: 3216-3226
21. Rovere-Querini P, et al: HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5: 825-830
22. Beyer C, et al: The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun 2012; 18: 727-737
23. Bell CW, Jiang W, Reich CF, Pisetsky DS: The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291:C1318-C1325
24. Gardella S, et al: The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3: 995-1001
25. Zhu H, et al: An efficient delivery of DAMPs on the cell surface by the unconventional secretion pathway. Biochem Biophys Res Commun 2011; 404: 790-795
26. Kaczorowski DJ, et al: Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 2009; 87: 1455-1463
27. Chen L, et al: TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282-2291
28. Yu M, et al: HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26: 174-179
29. Kruger B, et al: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395
30. Wu H, et al: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859
31. Park JS, et al: High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290:C917-C924
32. Andersson U, et al: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192: 565-570
33. Tsuboi N, et al: Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002; 169: 2026-2033
34. Wu H, et al: HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010; 21: 1878-1890
35. Junhua L, et al: Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischemic reperfusion injury. Nephrol Dial Transplant 2011; 26: 469-478
36. Veldt BJ, et al: Long-Term clinical outcome and effect of glycyrrhizin in 1,093 chronic hepatitis C patients with non-response or relapse to interferon. Scand J Gastroenterol 2006; 41: 1087-1094
37. Mabuchi A, Wake K, Marlini M, Watanabe H, Wheatley AM: Protection by glycyrrhizin against warm ischemia-reperfusion-induced cellular injury and derangement of the microcirculatory blood flow in the rat liver. Microcirculation 2009; 16: 364-376
38. Ogiku M, Kono H, Hara M, Tsuchiya M, Fujii H: Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats. J Pharmacol Exp Ther 2011; 339: 93-98
39. Kang DG, Sohn EJ, Mun YJ, Woo WH, Lee HS: Glycyrrhizin ameliorates renal function defects in the early phase of ischemia-induced acute renal failure. Phytother Res 2003; 17: 947-951
40. Mollica L, et al: Glycyrrhizin binds to highmobility group box 1 protein and inhibits its cytokine activities. Chem Biol 2007; 14: 431-441
41. Edwards JR, Diamantakos EA, Peuler JD, Lamar PC, Prozialeck WC: A novel method for the evaluation of proximal tubule epithelial cellular necrosis in the intact rat kidney using ethidium homodimer. BMC Physiol 2007; 7: 1
42. Suzuki C, et al: Participation of autophagy in renal ischemia/reperfusion injury. Biochem Biophys Res Commun 2008; 368: 100-106
43. Prodjosudjadi W, et al: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995; 48: 1477-1486
44. Gong G, et al: Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1. Acta Pharmacol Sin 2012; 33: 11-18
45. Linkermann A, et al: Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012; 81: 751-761
46. Lau A, et al: RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant 2013; 11: 2805-2818
47. Kazama H, et al: Induction of immunological tolerance by apoptotic cells requires caspasedependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32
48. Zhai CL, et al: Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway. Acta Pharmacol Sin 2012; 33: 1477-1487
49. Hung CC, et al: Upregulation of chemokine CXCL1/KC by leptospiral membrane lipoprotein preparation in renal tubule epithelial cells. Kidney Int 2006; 69: 1814-1822 Research